Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study

Background and Aim: Mild cognitive impairment (MCI) is characterized by declined cognitive function greater than that expected for a person’s age. The clinical significance of this condition is its possible progression to dementia. MLC601 is a natural neuroprotective medication that has shown promis...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hossein Pakdaman, Ali Amini Harandi, Mehdi Abbasi, Hosein Delavar Kasmaei, Farzad Ashrafi, Koroush Gharagozli, Farhad Assarzadegan, Behdad Behnam, Mehran Arabahmadi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Karger Publishers 2017-05-01
coleção:	Dementia and Geriatric Cognitive Disorders Extra
Assuntos:	Mild cognitive impairment MLC601 Placebo-controlled study Double-blind study Safety
Acesso em linha:	http://www.karger.com/Article/FullText/458521
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!